Illinois Senators Take Up Bill To Legalize Psilocybin And Create Service Centers In Committee Hearing
Schumer Circulates Petition For Marijuana Banking Bill As Pressure Builds For Vote
Indiana Governor Signs Psilocybin Research Funding Bill With Focus On Veterans And First Responders
Top Democratic Senator Calls Marijuana Banking Bill A ‘High Priority’ Amid Growing Calls For Reform
Germany Marijuana Legalization Law Will Take Effect On Schedule Next Month After Lawmakers Decline To Delay Implementation
CBD Has Potential To Manage Symptoms Of Alcohol Use Disorder, New Scientific Review Finds
USDA Approves Genetically Modified Hemp That Produces No THC Or CBD
Organ Donations From Marijuana Users Pose No Significant Infectious Risks, Study Finds
Study Finds Natural Psychedelic Mushrooms Produce ‘Enhanced Effects’ Compared To Synthesized Psilocybin, Suggesting Entourage Effect
Legalizing Marijuana For Adults Does Not Drive Increases In Youth Use, New Federally Funded Study Finds
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
Rapper Killer Mike Suggests Giving Black People Control Over Marijuana Industry As A Form Of Reparations
Brooklyn Nets And New York Liberty Become First NBA And WNBA Teams To Partner With CBD Company
UFC Warns Fighters To Stop Using Marijuana ‘Immediately’ So They Aren’t Punished Under California Athletics Rules
Massachusetts Marijuana Sales Pass $7 Billion Mark As Prices Hit Record Low
U.S. Company Offers Free Psychedelics Training Services To Ukraine Health Professionals To Treat Trauma From War With Russia
New Mexico Officials Celebrate Marijuana Milestone As Sales Cross $1 Billion Mark Since Recreational Market Launched
Missouri’s Marijuana Market Tallied More Than $1.4 Billion During First Full Year Of Adult-Use Sales
Missouri Marijuana Company Argues That Workers Are Not Allowed To Unionize Due To Federal Law
Treasury Secretary Yellen Says Passing Marijuana Banking Bill Would Be ‘Desirable’ To Address ‘Real Problem’
VA Asks Congress To Amend Medical Marijuana Bill For Veterans While Opposing Psychedelics Measure At Hearing
Congressman Tears Into Top Biden Official Over ‘Politically Damaging’ Lack Of Marijuana Reform Progress, Urging White House To ‘Follow Through’
Top Federal Health Official Clarifies Rescheduling Marijuana Wouldn’t Decriminalize It—Which Biden Campaigned On
Pennsylvania Joint Committee Takes Up Marijuana Legalization As Governor Renews Push For Reform
VA testifies on cannabis & psychedelics bills (Newsletter: March 22, 2024)
Congress has cannabis questions for Biden official (Newsletter: March 21, 2024)
IRS cannabis cash memo (Newsletter: March 20, 2024)
Inside VP’s cannabis meeting at White House (Newsletter: March 19, 2024)
VP Harris talks cannabis legalization & pardons (Newsletter: March 18, 2024)
Published
on
By
A North Carolina House committee has approved a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort.
The House Health Committee passed the legislation, filed by Rep. Edward Goodwin (R) and other bipartisan lawmakers last month, in a vote vote on Tuesday.
The measure wouldn’t legalize the psychedelics, but it would provide funding for two competitive grants through the state Department of Health and Human Services (HHS) for eligible research initiatives focused on “breakthrough therapies.”
Psilocybin and MDMA are cited as examples of such therapies that have received the special designation from the federal Food and Drug Administration (FDA).
“This bill is not a decriminalization. It is not for recreational purposes,” Goodwin said at Tuesday’s hearing. “It is simply a research study to get information that we will need when these drugs are available for proper implementation.”
Starting in August 2024, the department would be required to accept grant applications from in-state research entities and academic institutions that can show they’re capable of carrying out the studies, including clinical trials involving adults 21 and older.
The bill, which has now been referred to the House Appropriations Committee before potentially receiving consideration on the floor, says that “the recipient must attest that the grant funds will be used to conduct research in this State on the use of one of two psychedelics, MDMA and psilocybin, and that the research will adhere to all FDA protocols and all applicable federal law.”
For studies involving MDMA, researchers would need to explore the substance’s potential in the treatment of post-traumatic stress disorder (PTSD) for military veterans, first responders, frontline health professionals and people who have experienced domestic violence or sexual assault.
The psilocybin research would need to concentrate on how the psychedelic can affect anxiety and depressive disorder, while also measuring a patient’s pain levels with the treatment.
The grants are meant to fund three years of research, and recipients would need to submit a report with findings and recommendations to a Breakthrough Therapies Research Advisory Board and health department by January 15, 2028.
The board would be responsible for selecting the two grant recipients and notifying a joint legislative committee about their selection. Each recipient would receive $2.5 million.
Members of the board would need to include four people appointed by the governor; three members appointed by the House speaker; three members appointed by the Senate leader; one member of the Commission for Mental Health, Developmental Disabilities and Substance Abuse Services; the deputy secretary of health or a designee and the director of the Division of Mental Health, Developmental Disabilities and Substance Abuse Services or a designee.
Appointees would need to have backgrounds in psychedelic research, cultivation, mental health, law enforcement or be a person who is “disproportionately impacted by trauma” such as a military veteran or first responder.
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
This is one of a growing number of psychedelics bills that are being pursued in legislatures across the country this session.
Last week, for example, the governor of Arizona signed into law budget legislation that includes provisions to fund research into the medical potential of psilocybin mushrooms for a variety of conditions.
The Connecticut House of Representatives approved a bill last week to decriminalize possession of psilocybin mushrooms, sending it to the Senate.
The governor of Washington State signed a bill last week to promote research into psilocybin and create a pilot program to provide therapeutic access to the psychedelic for mental health treatment.
Vermont lawmakers held a committee hearing this month where members discussed legislation to legalize psilocybin and take first steps toward providing regulated access to the psychedelic.
A California bill to legalize the possession of certain psychedelics and facilitated use of the substances is heading to the Senate floor under an accelerated process that is allowing it to skip further committee consideration.
The Minnesota House recently passed an omnibus health bill that contains provisions to create a psychedelics task force meant to prepare the state for possible legalization.
Top New Hampshire Lawmakers Divided On State-Run Marijuana Legalization Plan Proposed By Governor
Minnesota Lawmakers Finalize Marijuana Legalization Bill In Conference Committee, With Passage Expected This Week
Salem, Massachusetts Lawmakers Vote To Decriminalize Psilocybin Mushrooms
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Illinois Senators Take Up Bill To Legalize Psilocybin And Create Service Centers In Committee Hearing
Schumer Circulates Petition For Marijuana Banking Bill As Pressure Builds For Vote
Indiana Governor Signs Psilocybin Research Funding Bill With Focus On Veterans And First Responders
Top Democratic Senator Calls Marijuana Banking Bill A ‘High Priority’ Amid Growing Calls For Reform
CBD Has Potential To Manage Symptoms Of Alcohol Use Disorder, New Scientific Review Finds
USDA Approves Genetically Modified Hemp That Produces No THC Or CBD
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell
North Carolina Lawmakers Approve Bill To Create $5 Million Psychedelic Research Grant Fund In Committee – Marijuana Moment
